Polysaccharides immobilized in polypyrrole matrices are able to induce osteogenic differentiation in mouse mesenchymal stem cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 12, 2014, Pages 989-999

  Moreno, Judith Serra ^a   Sabbieti, Maria Giovanna ^b   Agas, Dimitrios ^a,b   Marchetti, Luigi ^b   Panero, Stefania ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Differentiation; MSC; Polypyrrole; Polysaccharide; Release

Indexed keywords

ELECTROPOLYMERIZATION; HYALURONIC ACID; POLYPYRROLES; STEM CELLS; THIN FILMS; TISSUE REGENERATION;

BONE MARROW MESENCHYMAL; DIFFERENTIATION; IMMOBILISATION; MARROW MESENCHYMAL STEM CELLS; MATRIX; MESENCHYMAL STEM CELL; MESENCHYMAL TISSUES; OSTEOGENIC DIFFERENTIATION; RELEASE; THIN-FILMS;

CELL CULTURE;

ALIZARIN RED S; ALKALINE PHOSPHATASE; HEPARIN; HYALURONIC ACID; OSTEOCALCIN; POLYPYRROLE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; POLYMER; POLYSACCHARIDE; PYRROLE DERIVATIVE;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL VIABILITY ASSAY; CHEMICAL COMPOSITION; CONTROLLED STUDY; HYDROPHILICITY; IMMOBILIZATION; IN VITRO STUDY; MALE; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; POLYMERIZATION; THERMOSTABILITY; WATER TRANSPORT; ANIMAL; BONE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; INSTITUTE FOR CANCER RESEARCH MOUSE; MESENCHYMAL STROMA CELL; METABOLISM; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; BONE AND BONES; CELL DIFFERENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED ICR; POLYMERS; POLYSACCHARIDES; PYRROLES;

EID: 84919388302     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1601     Document Type: Article

References (34)

1. Agas D, Marchetti L, Menghi G et al. 2008; Anti-apoptotic Bcl-2 enhancing requires FGF-2/FGF receptor 1 binding in mouse osteoblasts. J Cell Physiol 214: 145-152.
2. Bramono DS, Murali S, Rai B et al. 2012; Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone 50: 954-964.
3. Castano H, O'Rear EA, McFetridge PS et al. 2004; Polypyrrole thin films formed by admicellar polymerization support the osteogenic differentiation of mesenchymal stem cells. Macromol Biosci 4: 785-794.
4. Gimble JM, Robinson CE, Wu X et al. 1996; Peroxisome proliferator-activated aeceptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 50: 1087-1094.
5. Guimard NK, Gómez N, Schmidt CE. 2007; Conducting polymers in biomedical engineering. Prog Polym Sci 32: 876-921.
6. Hartig M, Joos U, Wiesmann HP. 2000; Capacitively coupled electric fields accelerate proliferation of osteoblast-like primary cells and increase bone extracellular matrix formation in vitro. Eur Biophys J 29: 499-506.
7. Jaiswal RK, Jaiswal N, Bruder SP et al. 2000; Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275: 9645-9652.
8. Johnson MR, Boerckel JD, Dupont KM et al. 2011; Functional restoration of critically sized segmental defects with bone morphogenetic protein-2 and heparin treatment. Clin Orthop Relat Res 469: 3111-3117.
9. Khosla S, Westendorf JJ, Oursler MJ. 2008; Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118: 421-428.
10. Kim M, Shin Y, Hong BH et al. 2010; In vitro chondrocyte culture in heparin-based hydrogel for cartilage regeneration. Tissue Eng Part C Methods 16: 1-10.
11. Lazarenko OP, Rzonca SO, Suva LJ et al. 2006; Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. Bone 38: 74-84.
12. Lecka-Czernik B, Gubrij I, Moerman EJ et al. 1999; Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 74: 357-371.
13. Liu X, Yue Z, Higgins MJ et al. 2011; Conducting polymers with immobilised fibrillar collagen for enhanced neural interfacing. Biomaterials 32: 7309-7317.
14. Lundin V, Herland A, Berggren M et al. 2011; Control of neural stem cell survival by electroactive polymer substrates. PLoS One 6: e18624.
15. Montero A, Okada Y, Tomita M et al. 2000; Disruption of the fibroblast growth factor-2 results in decreased bone mass and bone formation. J Clin Invest 105: 1085-1093.
16. Naganawa T, Xiao L, Coffin JD et al. 2008; Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem 103: 1975-1988.
17. Ng LJ, Wheatley S, Muscat GE et al. 1997; SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183: 108-121.
18. Park KS, Ciaraldi TP, Lindgren K et al. 1998; Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma. J Clin Endocrinol Metab 83: 2830-2835.
19. Rodan GA, Martin TJ. 2000; Therapeutic approaches to bone diseases. Science 289: 1508-1514.
20. Rzonca SO, Suva LJ, Gaddy D, Montague et al. 2004; Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145: 401-406.
21. Sabbieti MG, Marchetti L, Abreu C et al. 1999; Prostaglandins regulate the expression of fibroblast growth factor-2 in bone. Endocrinology 140: 434-444.
22. Sabbieti MG, Agas D, Materazzi S et al. 2008; Prostaglandin F2alpha involves heparan sulphate sugar chains and FGFRs to modulate osteoblast growth and adifferentiation. J Cell Physiol 217: 48-59.
23. Sabbieti MG, Agas D, Xiao L et al. 2009; Endogenous FGF-2 is critically important in PTH anabolic effects on bone. J Cell Physiol 219: 143-151.
24. Sabbieti MG, Agas D, Marchetti L et al. 2010; Signaling pathways implicated in PGF2alpha effects on Fgf2+/+ and Fgf2-/- osteoblasts. J Cell Physiol 224: 465-474.
25. Sekiya I, Vuoristo JT, Larson BL et al. 2002; In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA 99: 4397-4402.
26. Serra Moreno J, Panero S. 2012; Evaluation of the interface aging of Polypyrrole-polysaccharide electrodes in a simulated physiological fluid. Electrochim Acta 68: 1-8.
27. Serra Moreno J, Panero S, Artico M et al. 2008a; Synthesis and characterization of new electroactive polypyrrole-chondroitin sulphate A substrates. Bioelectrochemistry 72: 3-9.
28. Serra Moreno J, Panero S, Scrosati B. 2008b; Electrochemical polymerization of polypyrrole-heparin nanotubes: Kinetics and morphological properties. Electrochim Acta 53: 2154-2160.
29. Serra Moreno J, Panero S, Materazzi S et al. 2009; Polypyrrole-polysaccharide thin films characteristics: Electrosynthesis and biological properties. J Biomed Mater Res 88A: 832-840.
30. Seto SP, Casas ME, Temenoff JS. 2011; Differentiation of mesenchymal stem cells in heparin-containing hydrogels via coculture with osteoblasts. Cell Tissue Res. DOI: 10.1007/s00441-011-1265-8
31. Soleimani M, Nadri S. 2009; A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4: 102-106.
32. Yonemori K, Matsunaga S, Ishidou Y et al. 1996; Early effects of electrical stimulation on osteogenesis. Bone 19: 173-180.
33. Zhang L, Stauffer WR, Jane EP et al. 2010; Enhanced differentiation of embryonic and neural stem cells to neuronal fates on laminin peptides doped polypyrrole. Macromol Biosci 10: 1456-1464.
34. Zhao Q, Eberspaecher H, Lefebvre V et al.1997; Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209: 377-386.